Biotech Company News

By Staff Reports 2 months ago

Faced with a preteen boy in pain and struggling to breathe from a severe, deteriorating

By Staff Reports 6 months ago

Pfizer‘s blockbuster rheumatoid arthritis drug Xeljanz, a JAK inhibitor, has been a strong performer for

By Staff Reports 6 months ago

Merck and Immune Design announced that the companies have entered into a definitive agreement under

By Staff Reports 6 months ago

CHICAGO (Reuters) – Gilead Sciences Inc said on Monday that a late-stage study of a

By Staff Reports 6 months ago

It’s a breath of fresh air for people with diabetics. A simple puff into a

By Staff Reports 7 months ago

Eureka Therapeutics, Inc., a clinical stage biotechnology company developing antibody-TCR (AbTCR) T-cell therapies, announced that

By Staff Reports 7 months ago

Shares of Q BioMed Inc.(OTCMKTS: QBIO) rose sharply on heavy volume after the company announced

By Staff Reports 8 months ago

Bristol-Myers bulks up cancer portfolio with $74 billion Celgene deal (Reuters) – Bristol-Myers Squibb Co

By Staff Reports 9 months ago

IntraBio Inc., a late-stage biopharmaceutical company developing novel therapies for rare “orphan” and common neurodegenerative

BioSpace